Market revenue in 2023 | USD 233.4 million |
Market revenue in 2030 | USD 287.6 million |
Growth rate | 3% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.96% in 2023. Horizon Databook has segmented the Middle East & Africa regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Growing population and increase in government efforts to improve access to healthcare are expected to attract global biopharmaceutical and medical companies in this market, thereby contributing to the demand for regulatory affairs services in the region.
Middle East and Africa region accounts for 6.0% of the total number of clinical trial applications and this number is expected to grow as a higher number of biopharmaceutical and medical device companies have started outsourcing of clinical trials in this region due to advancements in technology, cost-effectiveness, and easy patient recruitment process, thereby contributing to the rising demand for regulatory affair services.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa regulatory affairs outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account